ClinicalTrials.gg
CompletedNCT00877851LWDUpdated May 16, 2023Results posted

Evaluation of a Computer-Based, Self-Management Tool for People With Type 2 Diabetes

An interventional study of Computer-based Program in Diabetes Mellitus, Type 2, sponsored by Queen's University, Belfast. Completed at 2 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-16.

Sponsored by Queen's University, Belfast · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

NEW Brief Summary: Managing diet and physical activity are vital aspects of diabetes self-care; however, people with diabetes often find it difficult to make changes to their usual diet and physical activity patterns. There is some evidence that computer based education may help some people develop the skills they need to better manage their diabetes. The investigators have developed an external hard drive (a USB stick), focusing on knowledge, self-monitoring, goal setting and skill-development in relation to diet and physical activity for people with Type 2 diabetes. A major emphasis was placed on eliciting the views of people with Type 2 diabetes throughout the development of the computer based program. This study will examine whether this computer based program can improve knowledge, skills and self-care behaviour in people with diabetes. One hundred participants who have been diagnosed with Type 2 diabetes in the past 2 years will be assigned by chance to one of two groups: they will either be assigned to continue with their normal care routine consulting with their doctor as normal, or they will be assigned to use the USB stick at least once a week for 12 weeks.

02

Conditions studied

  • Diabetes Mellitus, Type 2

Keywords

  • Diet
  • Physical activity
  • Self management
  • Goal setting
03

In context

Diabetes Mellitus, Type 2

9,589 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,332 are open to participants now.

This study's enrollment of 84 is close to the median of 81 across 7,713 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Queen's University, Belfast is the lead sponsor of 116 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Medical diagnosis of Type 2 diabetes in the past 2 years
  • Have access to a computer on a regular basis

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating
  • Other medical conditions where changes in diet or physical activity would be contraindicated
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    1 Computer-based Program

    Use of Computer-based Program for 12 weeks

    Behavioral: Computer-based Program

  • No intervention
    2 Control

    Usual care and list of useful websites

Interventions

  • BehavioralComputer-based Program

    The intervention group will receive an initial training session which will include a demonstration of the layout and main features of the computer-based program and some instructions on how to navigate around the different sections of the program. As a minimum level of use, participants will be asked to use the self-monitoring and goal setting aspects of the computer-based program on at least a weekly basis.

06

What researchers measure

Primary outcomes

  1. Between Group Differences in Diabetes Knowledge

    ADKnowl questionnaire

    Time frame: 12 weeks

  2. Between Group Differences in Goal Setting

    Time frame: 12 weeks

Secondary outcomes

  1. Between Group Differences in Dietary Intake

    Time frame: 12 weeks

  2. Between Group Differences in Physical Activity Levels

    Time frame: 12 weeks

  3. Between Group Difference in Anthropometry

    Time frame: 12 weeks

  4. Between Group Differences in Markers of Cardiovascular Risk

    Time frame: 12 weeks

  5. Between Group Differences in Markers of Blood Glucose Control

    Time frame: 12 weeks

  6. Between Group Differences in Self-Efficacy and Barriers to Management of Diabetes

    Time frame: 12 weeks

07

Results

Posted May 16, 2023

Participant flow

Participant flow — Overall Study
Milestone1 Computer-based Program2 Control
Started4143
Completed3238
Not completed95
Withdrew: Lost to follow-up55
Withdrew: Computer problem30
Withdrew: No longer interested in participating10

Outcome measures

PrimaryBetween Group Differences in Diabetes Knowledge

ADKnowl questionnaire

Time frame:
12 weeks
Reported as:
Mean · Percent of items correct
Between Group Differences in Diabetes Knowledge
Percent of items correct1 Computer-based Program2 Control
Between Group Differences in Diabetes Knowledge67 ± 10.464 ± 14.2
PrimaryBetween Group Differences in Goal Setting
Time frame:
12 weeks

Results for this outcome have not been posted.

SecondaryBetween Group Differences in Dietary Intake
Time frame:
12 weeks

Results for this outcome have not been posted.

SecondaryBetween Group Differences in Physical Activity Levels
Time frame:
12 weeks

Results for this outcome have not been posted.

SecondaryBetween Group Difference in Anthropometry
Time frame:
12 weeks

Results for this outcome have not been posted.

SecondaryBetween Group Differences in Markers of Cardiovascular Risk
Time frame:
12 weeks

Results for this outcome have not been posted.

SecondaryBetween Group Differences in Markers of Blood Glucose Control
Time frame:
12 weeks

Results for this outcome have not been posted.

SecondaryBetween Group Differences in Self-Efficacy and Barriers to Management of Diabetes
Time frame:
12 weeks

Results for this outcome have not been posted.

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
1 Computer-based Program—0/41 (0%)0/41 (0%)
2 Control—0/43 (0%)0/43 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)1 Computer-based Program2 ControlTotal
Mean58 ± 9.160 ± 10.759 ± 9.9
Sex: Female, Male
Sex: Female, Male(Participants)1 Computer-based Program2 ControlTotal
Female191635
Male222749
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)1 Computer-based Program2 ControlTotal
Count of participants——0
08

Study locations

2 sites
  • Queen's University Belfast
    Belfast, Antrim BT12 6BJ, United Kingdom
  • Belfast Health and Social Care Trust
    Belfast, Antrim, United Kingdom
09

References and documents

Publications

  • Booth AO, Lowis C, Hunter SJ, Dean M, Cardwell CR, McKinley MC. Development and Evaluation of a Computer-Based, Self-Management Tool for People Recently Diagnosed with Type 2 Diabetes. J Diabetes Res. 2016;2016:3192673. doi: 10.1155/2016/3192673. Epub 2016 Jun 30. PubMed 27446961 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2009, a primary completion of Dec 2010 and a completion of Dec 2010. It does not say whether these dates are actual or estimated.

Results were first posted in May 2023, 12 years 5 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2009
First posted
Apr 8, 2009
Start
Apr 2009
Primary completionActual
Dec 2010
CompletionActual
Dec 2010
Results first posted
May 16, 2023
Last update
May 16, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00877851
Responsible party
Michelle McKinley (Dr Michelle McKinley, Queen's University, Belfast) — Principal investigator
First posted
Apr 8, 2009
Start date
Apr 2009
Primary completion
Dec 2010
Completion
Dec 2010
Results posted
May 16, 2023
Last update
May 16, 2023

Study contacts

Michelle McKinley, PhD
principal investigator · Queen's University, Belfast

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion